Impossible Foods is leveraging synbio to create novel plant-based meat analogs

June 12, 2018 | Case Study

Numerous factors – particularly taste, aroma, and texture – have held back producers of plant-based meat analogs from truly replicating the sensorial experience of their animal-based counterparts. Impossible Foods is looking to better mimic the mouthfeel of eating real beef by incorporating a novel ingredient into its plant-based meat analogs called leghemoglobin, a heme protein that imparts a bleeding effect and savory flavor. Although heme proteins are highly abundant in animal sources, they are only found in low amounts in plant sources like soy. To circumvent extraction procedures, the company is taking a synthetic biology approach by adding the soy leghemoglobin gene to yeast in order to produce the molecule via fermentation.

Login to View This Research

Already a Lux Client?

Not a Lux Client?

Talk to Lux Research now and learn the benefits of becoming a member.

Have Lux Research Call You

Lux Research

Helps clients find new business opportunities from emerging technologies in the physical and life sciences
Offers ongoing technology and market intelligence, as well as market data and consulting services
Now serves over 250 clients on six continents – multinational corporations, investors, governments, and SMEs
Has a Global reach, with offices in Boston, New York, Amsterdam, Singapore, and Tokyo
Combines deep technical expertise with business analysis to support strategic decisions

Or call us now

For North America (Boston Headquarters)
+1 (617) 502-5300

For EMEA (Amsterdam)
+31 (0) 20-3460840

For APAC (Singapore)
+65 6592-6978